Global Peripheral Drug Eluting Stent Market Research Report 2026(Status and Outlook)
Peripheral Drug Eluting Stent is a kind of medical device used to treat peripheral vascular stenosis or occlusive disease. It consists of a stent, usually made of metal, and a drug coating. The stent is inserted by balloon expansion or self-expansion to support narrow or blocked blood vessels and keep blood flow open. The drug coating is coated on the surface of the stent and contains drugs that inhibit the proliferation of vascular smooth muscle cells, such as paclitaxel or sirolimus, etc., which can be released slowly after stent implantation, reducing the risk of restenosis and thrombosis in the stent, and improving the long-term patency rate of blood vessels.
The global Peripheral Drug Eluting Stent market size was estimated at USD 5710.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Drug Eluting Stent market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Drug Eluting Stent market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Drug Eluting Stent market.
Global Peripheral Drug Eluting Stent Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boston Scientific
Medtronic
Abbot
W. L. Gore & Associates
iVascular SLU
Meril Life Sciences
Stentys SA
Cordis
Cook Medical
MicroPort Endovascular MedTech
Advanced Medical Technologies
LifeTech Scientific Corporation
Market Segmentation (by Type)
Metal Alloy Stent
Biodegradable Stent
Market Segmentation (by Application)
Hospitals
Mobile Surgery Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Drug Eluting Stent Market
Overview of the regional outlook of the Peripheral Drug Eluting Stent Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Drug Eluting Stent Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Drug Eluting Stent, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Peripheral Drug Eluting Stent market size was estimated at USD 5710.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Drug Eluting Stent market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Drug Eluting Stent market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Drug Eluting Stent market.
Global Peripheral Drug Eluting Stent Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boston Scientific
Medtronic
Abbot
W. L. Gore & Associates
iVascular SLU
Meril Life Sciences
Stentys SA
Cordis
Cook Medical
MicroPort Endovascular MedTech
Advanced Medical Technologies
LifeTech Scientific Corporation
Market Segmentation (by Type)
Metal Alloy Stent
Biodegradable Stent
Market Segmentation (by Application)
Hospitals
Mobile Surgery Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Drug Eluting Stent Market
Overview of the regional outlook of the Peripheral Drug Eluting Stent Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Drug Eluting Stent Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Drug Eluting Stent, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peripheral Drug Eluting Stent
1.2 Key Market Segments
1.2.1 Peripheral Drug Eluting Stent Segment by Type
1.2.2 Peripheral Drug Eluting Stent Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL DRUG ELUTING STENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Drug Eluting Stent Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Drug Eluting Stent Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL DRUG ELUTING STENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Drug Eluting Stent Product Life Cycle
3.3 Global Peripheral Drug Eluting Stent Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Drug Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Drug Eluting Stent Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Drug Eluting Stent Market Competitive Situation and Trends
3.8.1 Peripheral Drug Eluting Stent Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Drug Eluting Stent Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL DRUG ELUTING STENT INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Drug Eluting Stent Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL DRUG ELUTING STENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Drug Eluting Stent Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Drug Eluting Stent Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL DRUG ELUTING STENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Drug Eluting Stent Market Size by Type (2020-2025)
6.4 Global Peripheral Drug Eluting Stent Price by Type (2020-2025)
7 PERIPHERAL DRUG ELUTING STENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Drug Eluting Stent Market Sales by Application (2020-2025)
7.3 Global Peripheral Drug Eluting Stent Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL DRUG ELUTING STENT MARKET SALES BY REGION
8.1 Global Peripheral Drug Eluting Stent Sales by Region
8.1.1 Global Peripheral Drug Eluting Stent Sales by Region
8.1.2 Global Peripheral Drug Eluting Stent Sales Market Share by Region
8.2 Global Peripheral Drug Eluting Stent Market Size by Region
8.2.1 Global Peripheral Drug Eluting Stent Market Size by Region
8.2.2 Global Peripheral Drug Eluting Stent Market Size by Region
8.3 North America
8.3.1 North America Peripheral Drug Eluting Stent Sales by Country
8.3.2 North America Peripheral Drug Eluting Stent Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Drug Eluting Stent Sales by Country
8.4.2 Europe Peripheral Drug Eluting Stent Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Drug Eluting Stent Sales by Region
8.5.2 Asia Pacific Peripheral Drug Eluting Stent Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Drug Eluting Stent Sales by Country
8.6.2 South America Peripheral Drug Eluting Stent Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Drug Eluting Stent Sales by Region
8.7.2 Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL DRUG ELUTING STENT MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Drug Eluting Stent by Region(2020-2025)
9.2 Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Drug Eluting Stent Production
9.4.1 North America Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Drug Eluting Stent Production
9.5.1 Europe Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Drug Eluting Stent Production (2020-2025)
9.6.1 Japan Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Drug Eluting Stent Production (2020-2025)
9.7.1 China Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.7.2 China Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boston Scientific
10.1.1 Boston Scientific Basic Information
10.1.2 Boston Scientific Peripheral Drug Eluting Stent Product Overview
10.1.3 Boston Scientific Peripheral Drug Eluting Stent Product Market Performance
10.1.4 Boston Scientific Business Overview
10.1.5 Boston Scientific SWOT Analysis
10.1.6 Boston Scientific Recent Developments
10.2 Medtronic
10.2.1 Medtronic Basic Information
10.2.2 Medtronic Peripheral Drug Eluting Stent Product Overview
10.2.3 Medtronic Peripheral Drug Eluting Stent Product Market Performance
10.2.4 Medtronic Business Overview
10.2.5 Medtronic SWOT Analysis
10.2.6 Medtronic Recent Developments
10.3 Abbot
10.3.1 Abbot Basic Information
10.3.2 Abbot Peripheral Drug Eluting Stent Product Overview
10.3.3 Abbot Peripheral Drug Eluting Stent Product Market Performance
10.3.4 Abbot Business Overview
10.3.5 Abbot SWOT Analysis
10.3.6 Abbot Recent Developments
10.4 W. L. Gore and Associates
10.4.1 W. L. Gore and Associates Basic Information
10.4.2 W. L. Gore and Associates Peripheral Drug Eluting Stent Product Overview
10.4.3 W. L. Gore and Associates Peripheral Drug Eluting Stent Product Market Performance
10.4.4 W. L. Gore and Associates Business Overview
10.4.5 W. L. Gore and Associates Recent Developments
10.5 iVascular SLU
10.5.1 iVascular SLU Basic Information
10.5.2 iVascular SLU Peripheral Drug Eluting Stent Product Overview
10.5.3 iVascular SLU Peripheral Drug Eluting Stent Product Market Performance
10.5.4 iVascular SLU Business Overview
10.5.5 iVascular SLU Recent Developments
10.6 Meril Life Sciences
10.6.1 Meril Life Sciences Basic Information
10.6.2 Meril Life Sciences Peripheral Drug Eluting Stent Product Overview
10.6.3 Meril Life Sciences Peripheral Drug Eluting Stent Product Market Performance
10.6.4 Meril Life Sciences Business Overview
10.6.5 Meril Life Sciences Recent Developments
10.7 Stentys SA
10.7.1 Stentys SA Basic Information
10.7.2 Stentys SA Peripheral Drug Eluting Stent Product Overview
10.7.3 Stentys SA Peripheral Drug Eluting Stent Product Market Performance
10.7.4 Stentys SA Business Overview
10.7.5 Stentys SA Recent Developments
10.8 Cordis
10.8.1 Cordis Basic Information
10.8.2 Cordis Peripheral Drug Eluting Stent Product Overview
10.8.3 Cordis Peripheral Drug Eluting Stent Product Market Performance
10.8.4 Cordis Business Overview
10.8.5 Cordis Recent Developments
10.9 Cook Medical
10.9.1 Cook Medical Basic Information
10.9.2 Cook Medical Peripheral Drug Eluting Stent Product Overview
10.9.3 Cook Medical Peripheral Drug Eluting Stent Product Market Performance
10.9.4 Cook Medical Business Overview
10.9.5 Cook Medical Recent Developments
10.10 MicroPort Endovascular MedTech
10.10.1 MicroPort Endovascular MedTech Basic Information
10.10.2 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Overview
10.10.3 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Market Performance
10.10.4 MicroPort Endovascular MedTech Business Overview
10.10.5 MicroPort Endovascular MedTech Recent Developments
10.11 Advanced Medical Technologies
10.11.1 Advanced Medical Technologies Basic Information
10.11.2 Advanced Medical Technologies Peripheral Drug Eluting Stent Product Overview
10.11.3 Advanced Medical Technologies Peripheral Drug Eluting Stent Product Market Performance
10.11.4 Advanced Medical Technologies Business Overview
10.11.5 Advanced Medical Technologies Recent Developments
10.12 LifeTech Scientific Corporation
10.12.1 LifeTech Scientific Corporation Basic Information
10.12.2 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Overview
10.12.3 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Market Performance
10.12.4 LifeTech Scientific Corporation Business Overview
10.12.5 LifeTech Scientific Corporation Recent Developments
11 PERIPHERAL DRUG ELUTING STENT MARKET FORECAST BY REGION
11.1 Global Peripheral Drug Eluting Stent Market Size Forecast
11.2 Global Peripheral Drug Eluting Stent Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Drug Eluting Stent Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Drug Eluting Stent Market Size Forecast by Region
11.2.4 South America Peripheral Drug Eluting Stent Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Drug Eluting Stent by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Drug Eluting Stent Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Drug Eluting Stent by Type (2026-2035)
12.1.2 Global Peripheral Drug Eluting Stent Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Drug Eluting Stent by Type (2026-2035)
12.2 Global Peripheral Drug Eluting Stent Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Drug Eluting Stent Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Drug Eluting Stent Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peripheral Drug Eluting Stent
1.2 Key Market Segments
1.2.1 Peripheral Drug Eluting Stent Segment by Type
1.2.2 Peripheral Drug Eluting Stent Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL DRUG ELUTING STENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Drug Eluting Stent Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Drug Eluting Stent Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL DRUG ELUTING STENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Drug Eluting Stent Product Life Cycle
3.3 Global Peripheral Drug Eluting Stent Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Drug Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Drug Eluting Stent Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Drug Eluting Stent Market Competitive Situation and Trends
3.8.1 Peripheral Drug Eluting Stent Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Drug Eluting Stent Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL DRUG ELUTING STENT INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Drug Eluting Stent Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL DRUG ELUTING STENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Drug Eluting Stent Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Drug Eluting Stent Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL DRUG ELUTING STENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Drug Eluting Stent Market Size by Type (2020-2025)
6.4 Global Peripheral Drug Eluting Stent Price by Type (2020-2025)
7 PERIPHERAL DRUG ELUTING STENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Drug Eluting Stent Market Sales by Application (2020-2025)
7.3 Global Peripheral Drug Eluting Stent Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL DRUG ELUTING STENT MARKET SALES BY REGION
8.1 Global Peripheral Drug Eluting Stent Sales by Region
8.1.1 Global Peripheral Drug Eluting Stent Sales by Region
8.1.2 Global Peripheral Drug Eluting Stent Sales Market Share by Region
8.2 Global Peripheral Drug Eluting Stent Market Size by Region
8.2.1 Global Peripheral Drug Eluting Stent Market Size by Region
8.2.2 Global Peripheral Drug Eluting Stent Market Size by Region
8.3 North America
8.3.1 North America Peripheral Drug Eluting Stent Sales by Country
8.3.2 North America Peripheral Drug Eluting Stent Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Drug Eluting Stent Sales by Country
8.4.2 Europe Peripheral Drug Eluting Stent Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Drug Eluting Stent Sales by Region
8.5.2 Asia Pacific Peripheral Drug Eluting Stent Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Drug Eluting Stent Sales by Country
8.6.2 South America Peripheral Drug Eluting Stent Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Drug Eluting Stent Sales by Region
8.7.2 Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL DRUG ELUTING STENT MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Drug Eluting Stent by Region(2020-2025)
9.2 Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Drug Eluting Stent Production
9.4.1 North America Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Drug Eluting Stent Production
9.5.1 Europe Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Drug Eluting Stent Production (2020-2025)
9.6.1 Japan Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Drug Eluting Stent Production (2020-2025)
9.7.1 China Peripheral Drug Eluting Stent Production Growth Rate (2020-2025)
9.7.2 China Peripheral Drug Eluting Stent Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boston Scientific
10.1.1 Boston Scientific Basic Information
10.1.2 Boston Scientific Peripheral Drug Eluting Stent Product Overview
10.1.3 Boston Scientific Peripheral Drug Eluting Stent Product Market Performance
10.1.4 Boston Scientific Business Overview
10.1.5 Boston Scientific SWOT Analysis
10.1.6 Boston Scientific Recent Developments
10.2 Medtronic
10.2.1 Medtronic Basic Information
10.2.2 Medtronic Peripheral Drug Eluting Stent Product Overview
10.2.3 Medtronic Peripheral Drug Eluting Stent Product Market Performance
10.2.4 Medtronic Business Overview
10.2.5 Medtronic SWOT Analysis
10.2.6 Medtronic Recent Developments
10.3 Abbot
10.3.1 Abbot Basic Information
10.3.2 Abbot Peripheral Drug Eluting Stent Product Overview
10.3.3 Abbot Peripheral Drug Eluting Stent Product Market Performance
10.3.4 Abbot Business Overview
10.3.5 Abbot SWOT Analysis
10.3.6 Abbot Recent Developments
10.4 W. L. Gore and Associates
10.4.1 W. L. Gore and Associates Basic Information
10.4.2 W. L. Gore and Associates Peripheral Drug Eluting Stent Product Overview
10.4.3 W. L. Gore and Associates Peripheral Drug Eluting Stent Product Market Performance
10.4.4 W. L. Gore and Associates Business Overview
10.4.5 W. L. Gore and Associates Recent Developments
10.5 iVascular SLU
10.5.1 iVascular SLU Basic Information
10.5.2 iVascular SLU Peripheral Drug Eluting Stent Product Overview
10.5.3 iVascular SLU Peripheral Drug Eluting Stent Product Market Performance
10.5.4 iVascular SLU Business Overview
10.5.5 iVascular SLU Recent Developments
10.6 Meril Life Sciences
10.6.1 Meril Life Sciences Basic Information
10.6.2 Meril Life Sciences Peripheral Drug Eluting Stent Product Overview
10.6.3 Meril Life Sciences Peripheral Drug Eluting Stent Product Market Performance
10.6.4 Meril Life Sciences Business Overview
10.6.5 Meril Life Sciences Recent Developments
10.7 Stentys SA
10.7.1 Stentys SA Basic Information
10.7.2 Stentys SA Peripheral Drug Eluting Stent Product Overview
10.7.3 Stentys SA Peripheral Drug Eluting Stent Product Market Performance
10.7.4 Stentys SA Business Overview
10.7.5 Stentys SA Recent Developments
10.8 Cordis
10.8.1 Cordis Basic Information
10.8.2 Cordis Peripheral Drug Eluting Stent Product Overview
10.8.3 Cordis Peripheral Drug Eluting Stent Product Market Performance
10.8.4 Cordis Business Overview
10.8.5 Cordis Recent Developments
10.9 Cook Medical
10.9.1 Cook Medical Basic Information
10.9.2 Cook Medical Peripheral Drug Eluting Stent Product Overview
10.9.3 Cook Medical Peripheral Drug Eluting Stent Product Market Performance
10.9.4 Cook Medical Business Overview
10.9.5 Cook Medical Recent Developments
10.10 MicroPort Endovascular MedTech
10.10.1 MicroPort Endovascular MedTech Basic Information
10.10.2 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Overview
10.10.3 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Market Performance
10.10.4 MicroPort Endovascular MedTech Business Overview
10.10.5 MicroPort Endovascular MedTech Recent Developments
10.11 Advanced Medical Technologies
10.11.1 Advanced Medical Technologies Basic Information
10.11.2 Advanced Medical Technologies Peripheral Drug Eluting Stent Product Overview
10.11.3 Advanced Medical Technologies Peripheral Drug Eluting Stent Product Market Performance
10.11.4 Advanced Medical Technologies Business Overview
10.11.5 Advanced Medical Technologies Recent Developments
10.12 LifeTech Scientific Corporation
10.12.1 LifeTech Scientific Corporation Basic Information
10.12.2 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Overview
10.12.3 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Market Performance
10.12.4 LifeTech Scientific Corporation Business Overview
10.12.5 LifeTech Scientific Corporation Recent Developments
11 PERIPHERAL DRUG ELUTING STENT MARKET FORECAST BY REGION
11.1 Global Peripheral Drug Eluting Stent Market Size Forecast
11.2 Global Peripheral Drug Eluting Stent Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Drug Eluting Stent Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Drug Eluting Stent Market Size Forecast by Region
11.2.4 South America Peripheral Drug Eluting Stent Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Drug Eluting Stent by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Drug Eluting Stent Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Drug Eluting Stent by Type (2026-2035)
12.1.2 Global Peripheral Drug Eluting Stent Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Drug Eluting Stent by Type (2026-2035)
12.2 Global Peripheral Drug Eluting Stent Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Drug Eluting Stent Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Drug Eluting Stent Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Drug Eluting Stent Market Size by Type (M USD)
Table 4. Global Peripheral Drug Eluting Stent Market Size by Application
Table 5. Peripheral Drug Eluting Stent Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Drug Eluting Stent Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Drug Eluting Stent Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Drug Eluting Stent Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug Eluting Stent as of 2025)
Table 11. Global Market Peripheral Drug Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Drug Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Drug Eluting Stent Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Drug Eluting Stent Sales by Type (K Units)
Table 27. Global Peripheral Drug Eluting Stent Market Size by Type (M USD)
Table 28. Global Peripheral Drug Eluting Stent Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Drug Eluting Stent Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Drug Eluting Stent Market Share by Type (2020-2025)
Table 32. Global Peripheral Drug Eluting Stent Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Drug Eluting Stent Sales (K Units) by Application
Table 34. Global Peripheral Drug Eluting Stent Market Size by Application
Table 35. Global Peripheral Drug Eluting Stent Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Drug Eluting Stent Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Drug Eluting Stent Market Share by Application (2020-2025)
Table 39. Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025)
Table 44. North America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Drug Eluting Stent Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Boston Scientific Basic Information
Table 63. Boston Scientific Peripheral Drug Eluting Stent Product Overview
Table 64. Boston Scientific Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Boston Scientific Business Overview
Table 66. Boston Scientific SWOT Analysis
Table 67. Boston Scientific Recent Developments
Table 68. Medtronic Basic Information
Table 69. Medtronic Peripheral Drug Eluting Stent Product Overview
Table 70. Medtronic Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Medtronic Business Overview
Table 72. Medtronic SWOT Analysis
Table 73. Medtronic Recent Developments
Table 74. Abbot Basic Information
Table 75. Abbot Peripheral Drug Eluting Stent Product Overview
Table 76. Abbot Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbot Business Overview
Table 78. Abbot SWOT Analysis
Table 79. Abbot Recent Developments
Table 80. W. L. Gore and Associates Basic Information
Table 81. W. L. Gore and Associates Peripheral Drug Eluting Stent Product Overview
Table 82. W. L. Gore and Associates Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. W. L. Gore and Associates Business Overview
Table 84. W. L. Gore and Associates Recent Developments
Table 85. iVascular SLU Basic Information
Table 86. iVascular SLU Peripheral Drug Eluting Stent Product Overview
Table 87. iVascular SLU Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. iVascular SLU Business Overview
Table 89. iVascular SLU Recent Developments
Table 90. Meril Life Sciences Basic Information
Table 91. Meril Life Sciences Peripheral Drug Eluting Stent Product Overview
Table 92. Meril Life Sciences Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Meril Life Sciences Business Overview
Table 94. Meril Life Sciences Recent Developments
Table 95. Stentys SA Basic Information
Table 96. Stentys SA Peripheral Drug Eluting Stent Product Overview
Table 97. Stentys SA Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Stentys SA Business Overview
Table 99. Stentys SA Recent Developments
Table 100. Cordis Basic Information
Table 101. Cordis Peripheral Drug Eluting Stent Product Overview
Table 102. Cordis Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cordis Business Overview
Table 104. Cordis Recent Developments
Table 105. Cook Medical Basic Information
Table 106. Cook Medical Peripheral Drug Eluting Stent Product Overview
Table 107. Cook Medical Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cook Medical Business Overview
Table 109. Cook Medical Recent Developments
Table 110. MicroPort Endovascular MedTech Basic Information
Table 111. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Overview
Table 112. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. MicroPort Endovascular MedTech Business Overview
Table 114. MicroPort Endovascular MedTech Recent Developments
Table 115. Advanced Medical Technologies Basic Information
Table 116. Advanced Medical Technologies Peripheral Drug Eluting Stent Product Overview
Table 117. Advanced Medical Technologies Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Advanced Medical Technologies Business Overview
Table 119. Advanced Medical Technologies Recent Developments
Table 120. LifeTech Scientific Corporation Basic Information
Table 121. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Overview
Table 122. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. LifeTech Scientific Corporation Business Overview
Table 124. LifeTech Scientific Corporation Recent Developments
Table 125. Global Peripheral Drug Eluting Stent Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Peripheral Drug Eluting Stent Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Peripheral Drug Eluting Stent Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Peripheral Drug Eluting Stent Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Peripheral Drug Eluting Stent Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Peripheral Drug Eluting Stent Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Peripheral Drug Eluting Stent Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Peripheral Drug Eluting Stent Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Peripheral Drug Eluting Stent Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Drug Eluting Stent Market Size by Type (M USD)
Table 4. Global Peripheral Drug Eluting Stent Market Size by Application
Table 5. Peripheral Drug Eluting Stent Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Drug Eluting Stent Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Drug Eluting Stent Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Drug Eluting Stent Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug Eluting Stent as of 2025)
Table 11. Global Market Peripheral Drug Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Drug Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Drug Eluting Stent Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Drug Eluting Stent Sales by Type (K Units)
Table 27. Global Peripheral Drug Eluting Stent Market Size by Type (M USD)
Table 28. Global Peripheral Drug Eluting Stent Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Drug Eluting Stent Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Drug Eluting Stent Market Share by Type (2020-2025)
Table 32. Global Peripheral Drug Eluting Stent Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Drug Eluting Stent Sales (K Units) by Application
Table 34. Global Peripheral Drug Eluting Stent Market Size by Application
Table 35. Global Peripheral Drug Eluting Stent Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Drug Eluting Stent Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Drug Eluting Stent Market Share by Application (2020-2025)
Table 39. Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025)
Table 44. North America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Drug Eluting Stent Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Drug Eluting Stent Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Drug Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Boston Scientific Basic Information
Table 63. Boston Scientific Peripheral Drug Eluting Stent Product Overview
Table 64. Boston Scientific Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Boston Scientific Business Overview
Table 66. Boston Scientific SWOT Analysis
Table 67. Boston Scientific Recent Developments
Table 68. Medtronic Basic Information
Table 69. Medtronic Peripheral Drug Eluting Stent Product Overview
Table 70. Medtronic Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Medtronic Business Overview
Table 72. Medtronic SWOT Analysis
Table 73. Medtronic Recent Developments
Table 74. Abbot Basic Information
Table 75. Abbot Peripheral Drug Eluting Stent Product Overview
Table 76. Abbot Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbot Business Overview
Table 78. Abbot SWOT Analysis
Table 79. Abbot Recent Developments
Table 80. W. L. Gore and Associates Basic Information
Table 81. W. L. Gore and Associates Peripheral Drug Eluting Stent Product Overview
Table 82. W. L. Gore and Associates Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. W. L. Gore and Associates Business Overview
Table 84. W. L. Gore and Associates Recent Developments
Table 85. iVascular SLU Basic Information
Table 86. iVascular SLU Peripheral Drug Eluting Stent Product Overview
Table 87. iVascular SLU Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. iVascular SLU Business Overview
Table 89. iVascular SLU Recent Developments
Table 90. Meril Life Sciences Basic Information
Table 91. Meril Life Sciences Peripheral Drug Eluting Stent Product Overview
Table 92. Meril Life Sciences Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Meril Life Sciences Business Overview
Table 94. Meril Life Sciences Recent Developments
Table 95. Stentys SA Basic Information
Table 96. Stentys SA Peripheral Drug Eluting Stent Product Overview
Table 97. Stentys SA Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Stentys SA Business Overview
Table 99. Stentys SA Recent Developments
Table 100. Cordis Basic Information
Table 101. Cordis Peripheral Drug Eluting Stent Product Overview
Table 102. Cordis Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cordis Business Overview
Table 104. Cordis Recent Developments
Table 105. Cook Medical Basic Information
Table 106. Cook Medical Peripheral Drug Eluting Stent Product Overview
Table 107. Cook Medical Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cook Medical Business Overview
Table 109. Cook Medical Recent Developments
Table 110. MicroPort Endovascular MedTech Basic Information
Table 111. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Overview
Table 112. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. MicroPort Endovascular MedTech Business Overview
Table 114. MicroPort Endovascular MedTech Recent Developments
Table 115. Advanced Medical Technologies Basic Information
Table 116. Advanced Medical Technologies Peripheral Drug Eluting Stent Product Overview
Table 117. Advanced Medical Technologies Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Advanced Medical Technologies Business Overview
Table 119. Advanced Medical Technologies Recent Developments
Table 120. LifeTech Scientific Corporation Basic Information
Table 121. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Overview
Table 122. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. LifeTech Scientific Corporation Business Overview
Table 124. LifeTech Scientific Corporation Recent Developments
Table 125. Global Peripheral Drug Eluting Stent Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Peripheral Drug Eluting Stent Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Peripheral Drug Eluting Stent Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Peripheral Drug Eluting Stent Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Peripheral Drug Eluting Stent Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Peripheral Drug Eluting Stent Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Peripheral Drug Eluting Stent Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Peripheral Drug Eluting Stent Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Peripheral Drug Eluting Stent Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Peripheral Drug Eluting Stent Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Peripheral Drug Eluting Stent Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peripheral Drug Eluting Stent
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Drug Eluting Stent Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Drug Eluting Stent Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Drug Eluting Stent Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Drug Eluting Stent Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Drug Eluting Stent Product Life Cycle
Figure 13. Peripheral Drug Eluting Stent Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Drug Eluting Stent Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Drug Eluting Stent Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Drug Eluting Stent
Figure 19. Global Peripheral Drug Eluting Stent Market PEST Analysis
Figure 20. Global Peripheral Drug Eluting Stent Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Drug Eluting Stent Market Share by Type
Figure 27. Sales Market Share of Peripheral Drug Eluting Stent by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Drug Eluting Stent by Type in 2025
Figure 29. Market Share of Peripheral Drug Eluting Stent by Type (2020-2025)
Figure 30. Market Share of Peripheral Drug Eluting Stent by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Drug Eluting Stent Market Share by Application
Figure 33. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Drug Eluting Stent Sales Market Share by Application in 2025
Figure 35. Global Peripheral Drug Eluting Stent Market Share by Application (2020-2025)
Figure 36. Global Peripheral Drug Eluting Stent Market Share by Application in 2025
Figure 37. Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025)
Figure 40. North America Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 43. North America Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 45. U.S. Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Drug Eluting Stent Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Drug Eluting Stent Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Drug Eluting Stent Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Drug Eluting Stent Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 55. Germany Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Drug Eluting Stent Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Drug Eluting Stent Market Size by Region in 2024
Figure 68. China Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 80. South America Peripheral Drug Eluting Stent Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 82. Brazil Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Drug Eluting Stent Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Drug Eluting Stent Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Drug Eluting Stent Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Drug Eluting Stent Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Drug Eluting Stent Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Drug Eluting Stent Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Drug Eluting Stent Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Drug Eluting Stent Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Drug Eluting Stent Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Peripheral Drug Eluting Stent
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Drug Eluting Stent Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Drug Eluting Stent Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Drug Eluting Stent Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Drug Eluting Stent Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Drug Eluting Stent Product Life Cycle
Figure 13. Peripheral Drug Eluting Stent Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Drug Eluting Stent Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Drug Eluting Stent Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Drug Eluting Stent
Figure 19. Global Peripheral Drug Eluting Stent Market PEST Analysis
Figure 20. Global Peripheral Drug Eluting Stent Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Drug Eluting Stent Market Share by Type
Figure 27. Sales Market Share of Peripheral Drug Eluting Stent by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Drug Eluting Stent by Type in 2025
Figure 29. Market Share of Peripheral Drug Eluting Stent by Type (2020-2025)
Figure 30. Market Share of Peripheral Drug Eluting Stent by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Drug Eluting Stent Market Share by Application
Figure 33. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Drug Eluting Stent Sales Market Share by Application in 2025
Figure 35. Global Peripheral Drug Eluting Stent Market Share by Application (2020-2025)
Figure 36. Global Peripheral Drug Eluting Stent Market Share by Application in 2025
Figure 37. Global Peripheral Drug Eluting Stent Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Drug Eluting Stent Market Size by Region (2020-2025)
Figure 40. North America Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 43. North America Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 45. U.S. Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Drug Eluting Stent Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Drug Eluting Stent Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Drug Eluting Stent Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Drug Eluting Stent Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 55. Germany Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Drug Eluting Stent Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Drug Eluting Stent Market Size by Region in 2024
Figure 68. China Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Drug Eluting Stent Sales Market Share by Country in 2024
Figure 80. South America Peripheral Drug Eluting Stent Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Drug Eluting Stent Market Size by Country in 2024
Figure 82. Brazil Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Drug Eluting Stent Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Drug Eluting Stent Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Drug Eluting Stent Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Drug Eluting Stent Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Drug Eluting Stent Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Drug Eluting Stent Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Drug Eluting Stent Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Drug Eluting Stent Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Drug Eluting Stent Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Drug Eluting Stent Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Drug Eluting Stent Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Drug Eluting Stent Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Drug Eluting Stent Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Drug Eluting Stent Market Share Forecast by Application (2026-2035)
